Rezolute (RZLT) Gains from Investment Securities (2018 - 2021)
Rezolute (RZLT) posted Gains from Investment Securities of $14000.0 for Q1 2021, up 255.56% sequentially from -$9000.0 in Q4 2020, and up 158.33% YoY from $5419.4 in Q1 2020.
Powered by 
Analysis
Rezolute (RZLT) Gains from Investment Securities (2018 - 2021) Analysis & Trends
Rezolute has reported Gains from Investment Securities for 4 years, with the latest figure at $14000.0 in Q1 2021.
- Quarterly Gains from Investment Securities rose 158.33% year-over-year to $14000.0 in Q1 2021, while the trailing twelve-month figure through Jun 2021 was $8000.0 (down 89.87% YoY) and the FY2021 annual result came in at $8000.0, down 89.87% from the prior year.
- Gains from Investment Securities grew to $14000.0 in Q1 2021 per RZLT's latest filing, from -$9000.0 in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $98000.0 in Q4 2019 and troughed at -$24000.0 in Q1 2020.
- A 4-year average of $8745.9 and a median of $3000.0 in 2020 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2019 and 2020: Gains from Investment Securities jumped 9700.0% in 2019, then sank 700.0% in 2020.
- Over 4 years, Gains from Investment Securities stood at $1000.0 in 2018, then surged by 9700.0% to $98000.0 in 2019, then tumbled by 109.18% to -$9000.0 in 2020, then soared by 255.56% to $14000.0 in 2021.
- According to Business Quant data, Gains from Investment Securities over the past three periods registered $14000.0, -$9000.0, and $3000.0 for Q1 2021, Q4 2020, and Q3 2020 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Rezolute | 477.02 Mn | 477.02 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2021 | 14,000.00 |
| Dec 31, 2020 | -9,000.00 |
| Sep 30, 2020 | 3,000.00 |
| Jun 30, 2020 | 3,000.00 |
| Mar 31, 2020 | 3,000.00 |
| Dec 31, 2019 | 71,000.00 |
| Sep 30, 2019 | 2,000.00 |
| Jun 30, 2019 | 2,000.00 |
| Mar 31, 2019 | 4,000.00 |
| Dec 31, 2018 | 1,000.00 |
| Sep 30, 2018 | 5,000.00 |
| Jun 30, 2018 | 6,493.00 |
| Mar 31, 2018 | 8,204.00 |